Extension of Time to File SOU

RX METATYPE

Genomind, Inc.

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88318945
LAW OFFICE ASSIGNED LAW OFFICE 110
MARK SECTION
MARK RX METATYPE (see, http://uspto.report/TM/88318945/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT RX METATYPE
OWNER SECTION (current)
NAME Genomind, Inc.
MAILING ADDRESS 2200 Renissance Blvd., Ste 100
CITY King of Prussia
STATE Pennsylvania
ZIP/POSTAL CODE 19406
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
OWNER SECTION (proposed)
NAME Genomind, Inc.
MAILING ADDRESS 2200 Renissance Blvd., Ste 100
CITY King of Prussia
STATE Pennsylvania
ZIP/POSTAL CODE 19406
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Anita B. Polott
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@morganlewis.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) anita.polott@morganlewis.com
CORRESPONDENCE INFORMATION (proposed)
NAME Anita B. Polott
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@morganlewis.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) anita.polott@morganlewis.com; ennifer.evans@morganlewis.com; brittany.estell@morganlewis.com
DOCKET/REFERENCE NUMBER 122658-0010
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 044
CURRENT IDENTIFICATION Genetic testing for medical purposes
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 02/04/2020
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /Kip Olmstead/
SIGNATORY'S NAME Kip Olmstead
SIGNATORY'S POSITION President
DATE SIGNED 08/03/2020
SIGNATORY'S PHONE NUMBER 202.739.5286
FILING INFORMATION
SUBMIT DATE Mon Aug 03 22:26:15 ET 2020
TEAS STAMP USPTO/ESU-XXX.XXX.XXX.XX-
20200803222615319763-8831
8945-740c0de787260a9f47eb
027e96179e015926c84cef8cc
225bc184619f47b9ad5b-DA-2
6143903-20200803122822251
523



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: RX METATYPE (see, http://uspto.report/TM/88318945/mark.png)
SERIAL NUMBER: 88318945

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Genomind, Inc., having an address of
      2200 Renissance Blvd., Ste 100
      King of Prussia, Pennsylvania 19406
      United States
Proposed: Genomind, Inc., having an address of
      2200 Renissance Blvd., Ste 100
      King of Prussia, Pennsylvania 19406
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 02/04/2020.

For International Class 044:
Current identification: Genetic testing for medical purposes

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      Anita B. Polott
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@morganlewis.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): anita.polott@morganlewis.com

Correspondence Information (proposed):
      Anita B. Polott
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@morganlewis.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): anita.polott@morganlewis.com; ennifer.evans@morganlewis.com; brittany.estell@morganlewis.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Kip Olmstead/      Date Signed: 08/03/2020
Signatory's Name: Kip Olmstead
Signatory's Position: President
Signatory's Phone: 202.739.5286

RAM Sale Number: 88318945
RAM Accounting Date: 08/03/2020

Serial Number: 88318945
Internet Transmission Date: Mon Aug 03 22:26:15 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XXX.XXX.XX-202008032226153
19763-88318945-740c0de787260a9f47eb027e9
6179e015926c84cef8cc225bc184619f47b9ad5b
-DA-26143903-20200803122822251523




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed